Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.
about
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogsLigand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptorIsolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormoneAntagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissuesInhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxelGrowth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists.Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines.Expression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats.Comparison of expression of growth hormone-releasing hormone and its receptor splice variant 1 in different stages of endometriosis.Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors.Future perspectives for mTOR inhibitors in renal cell cancer treatment.Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer.Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines.Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
P2860
Q24292089-15119274-1F59-4E56-AC1C-69A46CC5FB07Q24309176-778182C1-48A6-4B2C-8937-A62DD8EE8DA9Q24652328-7497F62B-A1EB-438F-840A-BDB951BF5822Q33906715-BAF4DCF4-7D78-43F7-91FD-F156FE790F3EQ33927273-8BFDBB78-C9BF-420E-BD5F-195781C7FA95Q33933907-64A80E30-89F0-409C-91E2-CB627FBC1181Q34154583-29752670-ED3D-4DCB-BF43-655B1AF3726FQ34161110-8CCBE531-0653-44EB-B1B2-1F3CD2E0B93AQ34792237-4BAF08CA-FB43-42C2-84B5-8BC468A566A0Q35080727-369E0164-82AC-44DF-ACD2-D58BFA53B71AQ35185769-CCB49C1C-8209-401D-8DE0-32305F3412D0Q36161621-91BBE45C-0FDA-4D27-8AE5-70BA33F37FE0Q36696448-C2312E97-7D31-453C-B427-9053F1535B0EQ37077441-C1F659DE-D9B5-4940-9DC9-1E73F739464AQ37362896-A9693747-294C-4B15-9F74-25916705D718Q37589369-F5C00A83-0603-4801-ADF8-C51FEA6E891EQ38372445-291295CD-DFD9-487A-9115-D16F94C5C5FFQ40430581-7C21B69A-425E-46CC-AD26-DA37565CD84AQ42508371-08C5314E-62E4-43DE-9AC6-E3A7675286DCQ44059662-AF5251E1-B958-4907-9E50-E761730E59E1Q47441119-78AD9C07-D083-41BB-9C93-BF8C59859F3BQ48749343-1819102B-98B5-4216-BB0D-A4F3DB916354Q52544199-8FC48DC5-5340-4691-965D-893AD47AE090Q54684429-F456D9CF-81E6-48F3-B87C-D0531B59F5A2
P2860
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Human renal cell carcinoma exp ...... wth hormone-releasing hormone.
@ast
Human renal cell carcinoma exp ...... wth hormone-releasing hormone.
@en
type
label
Human renal cell carcinoma exp ...... wth hormone-releasing hormone.
@ast
Human renal cell carcinoma exp ...... wth hormone-releasing hormone.
@en
prefLabel
Human renal cell carcinoma exp ...... wth hormone-releasing hormone.
@ast
Human renal cell carcinoma exp ...... wth hormone-releasing hormone.
@en
P2093
P2860
P356
P1476
Human renal cell carcinoma exp ...... wth hormone-releasing hormone.
@en
P2093
P2860
P304
10555-10560
P356
10.1073/PNAS.180313097
P407
P577
2000-09-01T00:00:00Z